Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cannabis sativa L. inflorescence
- Development stage
- Unknown
- Lead developer
- Canndoc
- Administration
- Inhalation, Oral
01
Overview
Cannabis sativa L. inflorescence (CBD dominant) is a medical cannabis flower product developed by Canndoc, an Israeli medical cannabis company. It is a whole-plant, dried cannabis flower (inflorescence) modality — not an extract or synthetic compound — with cannabidiol (CBD) as the dominant active ingredient, alongside other naturally occurring cannabinoids and terpenes. As a medical cannabis flower, its primary biological targets include the endocannabinoid system receptors (CB1 and CB2), as well as other receptors modulated by CBD such as TRPV1 and serotonin receptors. The indications associated with this product — inherited from Canndoc's corresponding CBD-dominant oil formulations — include inflammatory bowel disease (IBD), post-traumatic stress disorder (PTSD), cancer pain, multiple sclerosis spasticity, epilepsy, adult epilepsy, and severe uncontrolled epilepsy in minors. It is a regulated medical cannabis product available in Israel through Canndoc's licensed cultivation and distribution framework.
- Other names
- cannabis sativa L. inflorescence (CBD dominant)CBD dominantmedical cannabis flower
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)5-HT (Serotonin receptors)
Beyond the preview
Go deeper on cannabis sativa L. inflorescence.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cannabis sativa L. inflorescence.